-+ 0.00%
-+ 0.00%
-+ 0.00%

MARVEL BIOSCIENCES CORP - PHASE I SINGLE ASCENDING DOSE STUDY FOR MB-204 TO BEGIN IN Q4 2026

Reuters·10/06/2026 10:45:00

Please log in to view news